Skip to main content
. 2020 Aug 10;43(3):440–444. doi: 10.1590/2175-8239-JBN-2020-0050

Figure 1. Laboratory values during follow-up.

Figure 1

*Started treatment with Eculizumab, **Increase in dose of Eculizumab